Celsion to Hold Second Quarter Conference Call Tuesday, August 9, 2005

August 4, 2005
Celsion to Hold Second Quarter Conference Call Tuesday, August 9, 2005COLUMBIA, Md.--(BUSINESS WIRE)--Aug. 4, 2005--CELSION CORPORATION (AMEX:CLN) today announced that it would hold its regular quarterly shareholders' conference call at 11:00 a.m. Eastern Time on Tuesday, August 9, 2005. To participate in the call, interested parties can dial 800.510.9661 (domestic) or 617.614.3452 (international), access code: 84808159# to register ten minutes before the call is scheduled to begin.

The call will be chaired by Dr. Lawrence Olanoff, Celsion's recently appointed President and Chief Executive Officer.

The call will be archived for replay on Tuesday, August 9, 2005 at 1:00 p.m. until Tuesday, August 16, 2005. The replay can be accessed at 888.286.8010 (domestic) or 617.801.6888 (international) access code: 71508686. The call will also be available on the Company's website, http://www.celsion.com for 90 days after 1:00 p.m. on Tuesday, August 9, 2005.

Celsion has research, license or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, Massachusetts Institute of Technology, Harbor UCLA Medical Center, Montefiore Medical Center and Memorial Sloan-Kettering Cancer Center in New York City, Roswell Park Cancer Institute in Buffalo, New York, and Duke University. For more information on Celsion, visit our website: http://www.celsion.com.

Celsion wishes to inform readers that forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, unforeseen changes in the course of research and development activities and in clinical trials by others; possible acquisitions of other technologies, assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.


    CONTACT: Celsion Corporation
             Tony Deasey, 410-290-5390
             tony@celsion.com
                 or
             Financial Relations Board
             General Info:
             Marilynn Meek, 212-827-3773
             mmeek@financialrelationsboard.com
                 or
             Investor Info:
             Susan Garland, 212-827-3775
             sgarland@financialrelationsboard.com

    SOURCE: Celsion Corporation